Liver transplantation for Hepatitis-B-associated liver disease - Three decades of experience.

Eva Maria TeegenMax Magnus MaurerBrigitta GlobkeJohann PratschkeDennis Eurich

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2018)

Uncontrolled HBV-reinfection does not occur any more. Even in the presence of Hbs-antigen, transplant fibrosis does not develop. The most reliable mode to prevent HBV-recurrence remains the combination of NUCs with a high genetic barrier and HBIG. However, HBIG can safely be discontinued after LT.

Keyphrases

hepatitis b virus
liver failure
genome wide
free survival
gene expression
liver fibrosis